7544.T
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥4.77 billion, representing 82.9% of total assets. The current ratio of 5.85 indicates a robust ability to meet short-term obligations. The price-to-book ratio of 1.01 and price-to-tangible-book ratio of 1.01 suggest that the company's market value closely aligns with its book value, with no significant intangible assets inflating the valuation. The debt-to-equity ratio of 0.0 confirms the absence of leverage, which reduces financial risk but may also limit growth potential.
Profitability metrics show a return on equity (ROE) of 9.25% and a return on assets (ROA) of 6.65%, both of which are in line with the industry's preferred metrics for capital efficiency. The operating margin is 9.4%, calculated as operating income of ¥1.41 billion divided by revenue of ¥15.08 billion. This margin is consistent with the industry's expectations for cost control and pricing power. The net profit margin of 2.54% reflects the company's ability to convert revenue into net income, though it is relatively modest compared to the industry median.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment or geographic breakdown in the financial data suggests that the company operates as a single integrated business, which may limit the ability to assess performance across different markets.
The company's growth trajectory is stable, with revenue of ¥15.08 billion in the latest period. While no specific growth rate is provided, the operating cash flow of ¥1.09 billion and free cash flow of ¥802 million indicate a strong cash-generating business. The capital expenditure of -¥8 million suggests minimal investment in new assets, which may reflect a mature business model with limited expansion opportunities.
Risk factors are minimal, with low liquidity and dilution risk identified. The absence of debt and the high cash reserves reduce the likelihood of liquidity stress. The dilution risk is also low, as the number of shares outstanding remains unchanged between basic and diluted shares. No immediate filing-based liquidity or dilution flags were detected, suggesting a stable capital structure.
Recent events include the latest financial filing, which disclosed the company's strong cash position and profitability. No significant changes in management, strategy, or regulatory environment were reported in the latest filings. The company's performance aligns with analyst estimates, with actual revenue and EPS matching the most recent reported figures.
- The company has a strong liquidity position with a current ratio of 5.85 and cash and equivalents of ¥4.77 billion.
- Profitability metrics such as ROE (9.25%) and ROA (6.65%) are in line with industry expectations.
- The company operates as a single business segment with no geographic diversification, increasing exposure to regional risks.
- Growth appears stable, with strong operating and free cash flow, but limited capital expenditure suggests a mature business model.
- Risk factors are minimal, with low liquidity and dilution risk, and no immediate filing-based flags detected.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 7544.T Market data — financials · 2026-05-27
- Three F Co Ltd Market data — analyst estimates · 2026-05-27